Works matching IS 20457634 AND DT 2016 AND VI 5 AND IP 4


Results: 19
    1
    2
    3
    4
    5

    PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 ( MM-398) or irinotecan with leucovorin/5-fluorouracil as second-line therapy in metastatic colorectal cancer.

    Published in:
    Cancer Medicine, 2016, v. 5, n. 4, p. 676, doi. 10.1002/cam4.635
    By:
    • Chibaudel, Benoist;
    • Maindrault‐Gœbel, Frédérique;
    • Bachet, Jean‐Baptiste;
    • Louvet, Christophe;
    • Khalil, Ahmed;
    • Dupuis, Olivier;
    • Hammel, Pascal;
    • Garcia, Marie‐Line;
    • Bennamoun, Mostefa;
    • Brusquant, David;
    • Tournigand, Christophe;
    • André, Thierry;
    • Arbaud, Claire;
    • Larsen, Annette K;
    • Wang, Yi‐Wen;
    • Yeh, C. Grace;
    • Bonnetain, Franck;
    • Gramont, Aimery
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Issue Information.

    Published in:
    Cancer Medicine, 2016, v. 5, n. 4, p. 605, doi. 10.1002/cam4.529
    Publication type:
    Article
    17
    18
    19